Largest companies by total assets
total assets
| Company | Total assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 101 | $412.47M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 102 | $411.90M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 103 | $406.45M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 104 | $404.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 105 | $396.96M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 106 | $394.72M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 107 | $393.97M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 108 | $392.02M | Healthcare | Pharmaceuticals | United States | NYSE |
| 109 | $383.36M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 110 | $376.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 111 | $368.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 112 | $368.35M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 113 | $361.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 114 | $349.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 115 | $345.41M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 116 | $337.64M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 117 | $330.83M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 118 | $330.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 119 | $327.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 120 | $323.95M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 121 | $318.63M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 122 | $316.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 123 | $302.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 124 | $302.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 125 | $298.88M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 126 | $296.87M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 127 | $287.60M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 128 | $286.83M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 129 | $285.13M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 130 | $283.25M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 131 | $281.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 132 | $280.51M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 133 | $279.38M | Healthcare | Pharmaceuticals | United States | NYSE |
| 134 | $274.02M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 135 | $264.56M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 136 | $254.07M | Healthcare | Pharmaceuticals | United States | NYSE |
| 137 | $253.51M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 138 | $252.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 139 | $250.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 140 | $249.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 141 | $248.02M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 142 | $246.29M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 143 | $246.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 144 | $244.36M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 145 | $232.28M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 146 | $231.97M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 147 | $229.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 148 | $220.67M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 149 | $215.33M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 150 | $215.13M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 151 | $203.39M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 152 | $202.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 153 | $195.46M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 154 | $192.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 155 | $192.14M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 156 | $189.88M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 157 | $189.36M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 158 | $189.31M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 159 | $183.14M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 160 | $182.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 161 | $182.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 162 | $181.63M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 163 | $179.51M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 164 | $179.35M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 165 | $175.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 166 | $165.30M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 167 | $163.45M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 168 | $160.82M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 169 | $159.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 170 | $154.25M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 171 | $151.01M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 172 | $148.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 173 | $145.38M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 174 | $142.97M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 175 | $142.26M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 176 | $141.40M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 177 | $134.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 178 | $133.65M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 179 | $132.10M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 180 | $127.62M | Healthcare | Pharmaceuticals | United States | NYSE |
| 181 | $126.96M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 182 | $126.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 183 | $126.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 184 | $124.13M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 185 | $121.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 186 | $115.81M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 187 | $113.14M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 188 | $112.85M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 189 | $112.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 190 | $111.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 191 | $105.01M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 192 | $103.90M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 193 | $102.85M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 194 | $101.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 195 | $101.08M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 196 | $99.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 197 | $99.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 198 | $98.36M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 199 | $98.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 200 | $95.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 342 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.